| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Apr 02, 2013 |
|||||||||
| Q1 FY13 | $0.28 | $0.28 | $934.40M | $918.01M |
NYSE |
||||
|
Global Payments
GPN
|
Q3 FY13 | $0.44 | $0.44 | $578.75M | $578.70M |
NYSE |
|||
|
Team
TISI
|
- | -$0.10 | $1.50 | $150.98M | $453M |
NYSE |
|||
|
G-III Apparel Group
GIII
|
Q4 FY13 | $0.20 | $0.20 | $375.28M | $375.30M |
NASDAQ |
|||
|
Oxford Industries
OXM
|
Q4 FY13 | $0.65 | $0.69 | $236.25M | $254.37M |
NYSE |
|||
|
Resources Connection
RGP
|
Q3 FY13 | $0.11 | $0.11 | $138.02M | $138.02M |
NASDAQ |
|||
|
SPAR Group
SGRP
|
Q4 FY12 | $0.06 | - | $30.95M | - |
NASDAQ |
|||
|
Transcontinental Realty Investors
TCI
|
- | -$0.75 | - | $29.05M | - |
NYSE |
|||
|
BioRestorative Therapies
BRTX
|
- | -$9.36 K | - | $364 | - |
NASDAQ |
|||
|
Catalyst Pharmaceuticals
CPRX
|
- | -$0.05 | -$0.09 | - | - |
NASDAQ |
|||
